Trials / Completed
CompletedNCT05254366
A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice
A Domestic, Prospective, Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,022 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 2000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Tosilate for Injection | Remimazolam Tosilate for Injection |
Timeline
- Start date
- 2022-01-30
- Primary completion
- 2023-02-08
- Completion
- 2023-02-08
- First posted
- 2022-02-24
- Last updated
- 2026-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05254366. Inclusion in this directory is not an endorsement.